EndeavorOTC™ Prospective Product Registry

Active, not recruitingOBSERVATIONAL
Enrollment

198

Participants

Timeline

Start Date

October 3, 2023

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
ADHD
Interventions
DEVICE

EndeavorOTC

EndeavorOTC™ is an over-the-counter digital therapeutic designed to improve attention function, ADHD symptoms, and quality of life in users 18 years of age and older with primarily inattentive or combined-type ADHD, who have been identified as having a significant attentional impairment. EndeavorOTC utilizes the same proprietary technology underlying EndeavorRx, a prescription digital therapeutic indicated to improve attention function in children ages 8-12. EndeavorOTC is not intended to be a replacement for any form of ongoing treatment. EndeavorOTC is deployed on mobile devices and incorporates adaptive, simultaneous cognitive tasks in a consumer-grade action videogame-based platform with high-quality graphics and reward mechanisms.

Trial Locations (1)

02110

Akili Interactive Labs, Inc., Boston

All Listed Sponsors
lead

Akili Interactive Labs, Inc.

INDUSTRY

NCT06109051 - EndeavorOTC™ Prospective Product Registry | Biotech Hunter | Biotech Hunter